Loading provider…
Loading provider…
Pulmonary Disease Physician in Chapel Hill, NC
NPI: 1225115785Primary Practice Location
UNC HOSPITALS
101 Manning Dr, Chapel Hill, NC
Primary Employer
UNC Faculty Physicians
uncmedicalcenter.org
HQ Phone
Get MD Scott's Phone NumberMobile
Get MD Scott's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 94729Measurement of lung diffusing capacity | 22 | 22 |
| 2 | 94375Test to measure rate of airflow | 21 | 21 |
| 3 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 19 | 32 |
| 4 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 17 | 17 |
| 5 | 99214Established patient office or other outpatient visit, 30-39 minutes | 17 | 24 |
Critical Care of the Adult Patient With Cystic Fibrosis.
Cystic fibrosis airway secretions exhibit mucin hyperconcentration and increased osmotic pressure.
Authors: Margaret Leigh, Ashley Henderson
Publication Date: 2014-06-04
Authors: John Clancy, Scott Sagel, Drucy Borowitz
Journal: Ann Am Thorac Soc
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebos, DRUG: CB-280
Lead Sponsor: AstraZeneca
Collaborators: Parexel
Intervention / Treatment: DRUG: Placebo, DRUG: AZD5634
Lead Sponsor: AbbVie
Intervention / Treatment: DRUG: Placebo, DRUG: ABBV-119, DRUG: ABBV-576, DRUG: Galicaftor, DRUG: Navocaftor